Also trades as: BOT.AX (ASX) · $vol 0M
BXPHF OTC
Botanix Pharmaceuticals Limited
1W: +46.8%
1M: -4.8%
3M: +40.4%
YTD: -79.8%
1Y: -88.1%
3Y: -86.6%
5Y: -77.1%
$0.02
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$34M
+498.6% ▲
5Y CAGR: +38.0%
Gross Profit
-$59M
-2659.6% ▼
Operating Income
-$69M
+19.8% ▲
Net Income
-$70M
+19.4% ▲
EPS (Diluted)
$-0.03
+31.2% ▲
EBITDA
-$69M
+15.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $3M | $4M | $2M | $6M | $34M |
| YoY Growth | -60.0% | +36.9% | -45.1% | +178.2% | +498.6% |
| Cost of Revenue | $10M | $4M | $4M | $3M | $94M |
| Gross Profit | -$8M | -$3M | -$2M | $2M | -$59M |
| Gross Margin | -273.6% | -80.7% | -76.5% | 40.3% | -172.2% |
| R&D Expenses | $10M | $6M | $2M | $144K | $0 |
| SG&A Expenses | $4M | $4M | $7M | $71M | $10M |
| Operating Expenses | $15M | $10M | $14M | $89M | $10M |
| Operating Income | -$22M | -$14M | -$15M | -$86M | -$69M |
| Operating Margin | -814.8% | -360.8% | -747.0% | -1499.7% | -200.8% |
| Interest Expense | $37K | $82K | $11K | $2M | $3M |
| Income Before Tax | -$13M | -$9M | -$14M | -$86M | -$70M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$13M | -$9M | -$14M | -$86M | -$70M |
| Net Margin | -478.1% | -242.7% | -670.2% | -1500.6% | -202.2% |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.05 | $-0.03 |
| EBITDA | -$13M | -$9M | -$14M | -$82M | -$69M |
| Shares Outstanding | 973M | 1.15B | 1.50B | 1.84B | 2.16B |